Abstract
H. Einfeldt’s historical review makes it quite clear that the use of testosterone (anabolic steroids) in the treatment of CVD is by no means a modern idea. Nevertheless, in spite of the great interest shown in testosterone treatment of CVD, it would almost seem that the development has slowed down in this important field. There may be several reasons for this. One of them might be the Second World War; naturally enough it must have delayed possibilities for cooperation since Germany was the “cradle” of hormones, as is evident from what has been written up to now. Interest was again aroused when CVD was described universally, and particularly in America, as a new plague for mankind. Billions of dollars have been invested in the search for the cause and a method of combatting it, and statistics have been assembled which have aroused apprehension throughout the civilized world. The press has, no doubt unconsciously, overemphasized the seriousness of this disease, the danger of which is magnified in people’s minds by the attention drawn to it every time a well-known person dies suddenly, presumably but not assuredly from CVD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Møller, J., Einfeldt, H. (1984). Significance of Cardiovascular Disease (CVD). In: Testosterone Treatment of Cardiovascular Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-61744-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-61744-7_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-61746-1
Online ISBN: 978-3-642-61744-7
eBook Packages: Springer Book Archive